Abstract
Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Current Organic Chemistry
Title: Docosahexaenoic Acid and Membrane Lipid Domains
Volume: 4 Issue: 11
Author(s): William Stillwell
Affiliation:
Abstract: Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Export Options
About this article
Cite this article as:
Stillwell William, Docosahexaenoic Acid and Membrane Lipid Domains, Current Organic Chemistry 2000; 4 (11) . https://dx.doi.org/10.2174/1385272003375860
DOI https://dx.doi.org/10.2174/1385272003375860 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Lipid Mediator Profiling in Pulmonary Disease
Current Pharmaceutical Biotechnology Status of Cytokines in Ischemia Reperfusion Induced Heart Injury
Cardiovascular & Hematological Disorders-Drug Targets Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
Current Pharmaceutical Design Trends in the Design and Application of Optical Chemosensors in Pharmaceutical and Biomedical Analysis
Current Pharmaceutical Analysis Cardioprotective Role of <i>Theobroma cacao</i> against Isoproterenol-Induced Acute Myocardial Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Editorial [Hot Topic: Perspectives of New Antihypertensive Drugs (Executive Editor: Ji-Guang Wang)]
Current Pharmaceutical Design The Immunoproteasome as a Therapeutic Target for Hematological Malignancies
Current Cancer Drug Targets Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation
CNS & Neurological Disorders - Drug Targets Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders
Current Topics in Medicinal Chemistry “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Genetic Determinants of Severe Respiratory Syncytial Virus Infection and Post-Bronchiolitis Wheeze: A Systematic Review
Current Respiratory Medicine Reviews From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Current Pharmaceutical Design Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion
Current Pharmaceutical Design Mechanisms of Salt-Sensitive Hypertension
Current Hypertension Reviews Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Medicinal Chemistry of 2,2,4-Substituted Morpholines
Current Medicinal Chemistry Biomarkers in Aortic Valve Stenosis and their Clinical Significance in Transcatheter Aortic Valve Implantation
Current Medicinal Chemistry Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets